The acute lung injury resulting from adult respiratory distress syndrome (ARDS) is thought to be largely mediated by activated neutrophils. Because activated neutrophils produce the superoxide radical, which is both bactericidal and cytotoxic to host cells, this oxygen-derived free radical is likely responsible for at least part of the neutrophil-mediated lung injury. In a rat model of ARDS resulting from intratracheal instillation of interleukin-1, recombinant human manganous superoxide dismutase significantly decreased lung leak. One detrimental action of proteases released by adherent neutrophils may be the degradation of extracellular superoxide dismutase (ECSOD), which normally binds to the heparan sulfate on the surface of the endothelium. We found that rabbit ECSOD incubated with either trypsin or activated neutrophils loses affinity for heparin. Furthermore, soluble ECSOD is elevated in the serum of patients with ARDS, consistent with this hypothesis. -Environ Health Perspect 1 02(Suppl 10): 57-60 (1994) 
Introduction
Adult respiratory distress syndrome (ARDS) is a common and frequently lethal complication of a number of conditions, especially sepsis and trauma. The mortality remains at around 50%, resulting from leakage of fluid into the pulmonary interstitium and alveoli (1) . Considerable evidence implicates the neutrophil as a primary source of injury to the lungs (2) . In addition, there are numerous indications that patients with ARDS are in oxidative stress, including elevated levels of hydrogen peroxide in their expired breath (3), oxidatively inactivated antiprotease in their blood and lavage fluid (4) , lipid peroxidation products in their blood (5) , and decreased levels of reduced glutathione in blood and alveolar lining fluids (6) .
In many laboratory models and in a few clinical trials, superoxide dismutase (SOD) has proven therapeutically useful in protecting injured tissues from superoxide radical, whether generated intracellularly or by infiltrating activated neutrophils (7) . Its ability to protect tissues against any particular insult (ischemia, inflammation, hyper-oxia, etc.) depends on several parameters, such as the rate of plasma clearance (8) , the ability to equilibrate between extracellular fluid compartments (9) , and the ability to closely approach negatively charged cell surfaces by virtue of its own net charge (10) .
In humans, three types of SOD have been extensively characterized: the cytosolic Cu,Zn-SOD, a 32-kDa dimer (11), the mitochondrial Mn-SOD, an 89-kDa tetramer (12) , and an extracellular SOD (ECSOD) (13) . This ECSOD (a 135,000-mw tetrameric glycoprotein) is also a cuprozinc enzyme. ECSOD is genetically related to the smaller cytosolic enzyme, and is found in a number of tissues but at a much lower concentration than either of the other two enzymes (14, 15) . However, the major SOD in extracellular fluids is the ECSOD. It is found as three post translationally generated isozymes: ECSOD-A with no heparin affinity; ECSOD-B with low heparin affinity; and ECSOD-C with high heparin affinity, causing it to be largely bound to heparan sulfate on endothelial surfaces. The affinity for polyanions is due to a highly hydrophilic, positively charged carboxy-terminal "tail" on each subunit of ECSOD-C (the native form) (16 (19) . Rabbit ECSOD-C was purified by administering a lethal dose of sodium pentobarbital (60 mg/kg) to a rabbit also injected iv with 200 U heparin/kg bw. The rabbit was exsanguinated and the blood centrifuged to remove the cells. The plasma was fractionated by heparin affinity chromatography as described below. After elution by the sodium chloride gradient, the peak fractions were dialyzed against HBSS and concentrated by ultrafiltration (Amicon, PM-10 membrane).
Heparin Affinity Chromatography A sample of SOD (500-2000 U) was applied to a small (2-3 ml bed volume) column of heparin-agarose (Sigma) in 10 mM Tris-Cl buffer, pH 7.4. The column was washed with this buffer to remove unbound enzyme, then eluted with a gradient of NaCl, 0 to 2.0 M. Fractions were assayed for SOD activity and for conductivity. Native Cu,Zn-or Mn-SODs showed no affinity for this column; rabbit ECSOD-C was retained by the column, eluting at 0.4 M NaCl.
Neutrophil Isolation and Activation
Human peripheral neutrophils were isolated from freshly drawn blood obtained from healthy donors as previously described (20) and resuspended in HBSS at 1 x 107 cells/ml. The neutrophils were activated by 1 added to 120 U of rabbit ECSOD-C in 0.5 ml of HBSS and incubated for 1 hr at 37°C. The solution was then subjected to heparin-agarose affinity chromatography as described above. The results (Figure 2) show that while the native ECSOD-C binds to the heparin column and is eluted at a salt concentration of about 0.4 M, the trypsinized ECSOD-C lost all affinity for the heparin column.
Activated Neutrophils Decrease the Heparin Affinity ofECSOD
Isolated human neutrophils from a healthy donor were 8resuspended at a concentration of 1.4 x 10 cells/ml in HBSS containing rabbit ECSOD-C (240 U/ml). The cells in one aliquot (0.5 ml) were activated by the addition of 1 pM phorbol myristate acetate.
The mixtures were then incubated for 1 hr at 37°C and each was subjected to heparinagarose affinity chromatography. The results (Figure 3) show that while resting neutrophils did not affect the affinity of the enzyme for heparin, incubation with activated neutrophils decreased the interaction degranulate, a variety of proteolytic enzymes is released. We have found that activated neutrophils are capable of causing partial proteolysis of ECSOD-C, resulting in a diminished affinity for the endothelial surface. These hypothetical changes are illustrated in Figure 5 .
Karlsson et al. (22) have also noted that plasmin as well as trypsin can abolish the heparin affinity of ECSOD-C. This vulnerability of ECSOD-C to proteolysis, we believe, raises the possibility of its involvement in a wide range of diseases that produce increased levels of proteolytic activity in the plasma (whether locally or systemically), as well as increased levels of oxida- tive stress. The phenomenon also casts new light on the therapeutic use of superoxide dismutases. A relatively high concentration of soluble SOD in the extracellular fluid may not be able to provide the necessary protection to the endothelium that could be provided by a much smaller amount of SOD if it were bound to the cell surfaces. Note that in Figure 1 the exogenously administered Mn-SOD provided significant protection to the IL-1-treated lung, but not maximal protection. This might mean, of course, that the injury is not totally superoxide-mediated, or it might mean the effective concentration of SOD at the endothelial surface was simply inadequate.
